Company Search:
Advanced Search
Sponsored Links
Abnova (Taiwan) Corporation Company Snapshot
Abnova (Taiwan) Corporation operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Abnova (Taiwan) with three other companies in this sector in TAIWAN : EirGenix Inc (2019 sales of 476.09 million Taiwanese Dollars [US$16.72 million] of which 100% was Antibody and Protein Medicine Developmen), Genmont Biotech Inc (346.24 million Taiwanese Dollars [US$12.16 million] of which 100% was Jingyue Company), and Mycenax Biotech Incorporated (390.84 million Taiwanese Dollars [US$13.72 million] of which 99% was Technical Service Income).

Sales Analysis. During the year ended December of 2019, sales at Abnova (Taiwan) were 414.16 million Taiwanese Dollars (US$14.54 million). This is a decrease of 2.8% versus 2018, when the company's sales were 426.02 million Taiwanese Dollars . The sales level in 2019 was fairly close to the level five years ago: in 2014, Abnova (Taiwan) had sales of 438.11 million Taiwanese Dollars . Contributing to the drop in overall sales was the 75.9% decline in Equipment, from 43.62 million Taiwanese Dollars to 10.50 million Taiwanese Dollars . There were also decreases in sales in Paired Antibodies (down 4.9% to 77.45 million Taiwanese Dollars ) and Multiple Strains of Antibodies (down 2.8% to 42.03 million Taiwanese Dollars ) . However, these declines were partially offset by the increase in sales of Monoclonal Antibodies (up 9.9% to 128.64 million Taiwanese Dollars ) and Others (up 12.3% to 91.07 million Taiwanese Dollars ) and Protein (up 8.1% to 64.47 million Taiwanese Dollars ) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Abnova (Taiwan) Corporation
  Stock Performance Chart for Abnova (Taiwan) Corporation
  Stock Data: Recent Stock Performance:
  Current Price (11/20/2020): 62.90
(Figures in Taiwanese Dollars )
1 Week 2.4%   13 Weeks -9.4%  
4 Weeks -25.1%   52 Weeks 134.3%  
Abnova (Taiwan) Corporation Key Data:
  Ticker: 4133 Country: Taiwan
  Exchanges: TAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2019 Sales 414,158,000
(Year Ending Jan 2020).
Employees: 190
  Currency: Taiwanese Dollars Market Cap: 3,808,846,600
  Fiscal Yr Ends: December Shares Outstanding: 60,554,000
  Share Type: Gu Closely Held Shares: 21,607,000
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.